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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYMetabotropic glutamate receptor7 (GRM7)has recentlybeen identified tobe associatedwithbraindevelopmental defects, suchas attention
deficit hyperactivity disorder (ADHD) and autism. However, the function of GRM7 during brain development remains largely unknown.
Here, we used gain- and loss-of-function strategies to investigate the role of GRM7 in early cortical development. We demonstrate that
Grm7 knockdown increases neural progenitor cell (NPC) proliferation, decreases terminal mitosis and neuronal differentiation, and leads
to abnormal neuronal morphology. GRM7 regulates the phosphorylation of cyclic AMP response element-binding protein (CREB) and
the expression of Yes-associated protein (YAP) by directly interacting with CaM, which subsequently regulates the expression of CyclinD1
and ultimately affects early cortical development. These defects inneurogenesis are ameliorated byGrm7overexpression,Creb knockdown,
or Yap knockdown. Thus, our findings indicate that GRM7 signaling via CREB and YAP is necessary for neurogenesis in the brain.INTRODUCTION
The complex structure of the mammalian cerebral cortex is
derived from neuroepithelial (NE) cells in the neural tube
(McConnell, 1995). NE cells give birth to multiple progen-
itor populations (Go¨tz and Huttner, 2005; McConnell,
1995). There are two germinal zones in the embryonic
neocortex: the ventricular zone (VZ) and the subventricu-
lar zone (SVZ) (Gal et al., 2006). Radial glial (RG) cells
give rise to self-renewing cells and produce intermediate
progenitor (IP) cells via asymmetrical division. IP cells sub-
sequently divide into two neurons via symmetrical divi-
sion (Go¨tz and Huttner, 2005; McConnell, 1995; Rakic,
1995). During the process of progenitor cell transformation
into mature neurons, the precise control of the timing
of self-renewal, differentiation, neuronal migration, and
neuronal maturation of neural progenitor cells (NPCs) is
required (Xu et al., 2014). Therefore, it is not surprising
that mistakes in this process of early cortical development
lead to serious consequences, such as autism spectrum dis-
order (ASD) and attention deficit hyperactivity disorder
(ADHD).
Metabotropic glutamate receptor 7 (GRM7) is defined as
an ASD- (Yang and Pan, 2013) and ADHD-related gene (Elia
et al., 2012) and is exclusively expressed in the CNS (Brad-
ley et al., 1996). Metabotropic glutamate receptors are po-
tential targets for neuropsychiatric disorders (Dev, 2004)
that modulate neurotransmitter release and neuronal
excitability (Schlett, 2006). Metabotropic glutamate recep-
tors are subdivided into groups I (GRM1 and GRM5), II
(GRM2 and GRM3), and III (GRM4, GRM6, GRM7, and
GRM8) on the basis of homology, intracellular messengers,
and ligand selectivity (Schlett, 2006). Characteristic of all
metabotropic glutamate receptors, the GRM7 protein isStemlocalized to the neuronal presynaptic membrane, and its
protein sequence is highly conserved (Bradley et al.,
1996). These findings suggest that GRM7 may play an
important and irreplaceable role in the nervous system.
However, its role in the process of cortical development is
unclear.
During neurogenesis, cyclic AMP response element-
binding protein (CREB) is involved in multiple aspects of
neuronal development and plasticity, including cell sur-
vival, proliferation, and differentiation (Mantamadiotis
et al., 2012). CREB is expressed throughout neurogenesis
(Giachino et al., 2005), and a previous study has shown
that neural proliferation defects result from the alteration
of CREB activity during early development (Dworkin
et al., 2007). Yes-associated protein (YAP) modulates organ
size by regulating cell apoptosis and proliferation (Cai
et al., 2010; Lian et al., 2010). YAP is expressed in mitotic
neuronal progenitors, and it is downregulated during
neuronal differentiation (Zhang et al., 2012). The phos-
phorylation of YAP at Ser127 results in a loss of function
and the subsequent repression of downstream target genes,
leading to premature neuronal differentiation (Cao et al.,
2008). In the absence of inhibitory phosphorylation, YAP
promotes cell proliferation and suppresses cell differentia-
tion (Zhang et al., 2012). During neurogenesis, CYCLIND1
plays an important role in neural progenitor proliferation;
when CYCLIND1 is constitutively activated, the prolifera-
tion of NPCs is increased (Das et al., 2010). To investigate
the function of GRM7 in early cortical development,
we downregulated its expression in neuronal progenitor
cells of the cerebral ventricle of embryos via in utero elec-
troporation (IUE). We determined that Grm7 knockdown
increases the proliferation of PAX6-positive RG cells,
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results in a reduction in the number of progenitor cells that
differentiate into neurons. Furthermore, morphological
maturation was seriously affected by the silencing of
Grm7. We also demonstrated that Creb or Yap knockdown
ameliorates the Grm7 knockdown phenotype in vivo.
Overall, our findings suggest that GRM7 regulates the
phosphorylation of CREB and the expression of YAP in
neuronal progenitor cells, affecting the expression of
CyclinD1, which ultimately controls neuronal differentia-
tion and maturation during cortical development.RESULTS
GRM7 Is Expressed in Neural Progenitor Cells
During cortical development, GRM7 displays a specific
temporal and spatial expression pattern. To determine
whether the GRM7 protein is expressed in brain tissue
during different developmental periods, we performed
western blot to analyze its expression pattern. Our results
showed that the GRM7 protein expressed was already
detectable at embryonic day 12.5 (E12.5), gradually in-
creased until E15.5, and then dramatically decreased be-
tween E15.5 and E18.5 (Figure 1A). This finding suggests
that GRM7may play an important role in early embryonic
cortical development. Neocortical sections of E12.5, E15.5,
and E18.5 mouse brains were collected and immuno-
stained for GRM7, and the results showed that its expres-
sion pattern was dynamic in the VZ/SVZ. At E12.5, in
which the cerebral cortex is primarily composed of NPCs,
we determined that the GRM7 protein was expressed
throughout the cortex. At E15.5, GRM7 protein was highly
expressed in the VZ/SVZ. However, at E18.5, which is near
the end of the embryonic neurogenesis period, the expres-
sion of GRM7 in the cerebral cortical plate was higher than
that in the VZ/SVZ (Figure 1B). In the embryonic cerebral
cortex, we determined that the GRM7 protein colocalized
with NESTIN- and PAX6-positive neuronal progenitor cells
residing in the VZ/SVZ at E15.5 (Figures 1C and 1D). More-
over, we determined that GRM7 colocalized with NESTIN-
and PAX6-positive cultured neuronal progenitor cells,
which were isolated from E12.5 mouse brains and cultured
in proliferative medium for 24 hr (Figures S1A and S1B).
Additionally, based on in situ hybridization, Grm7 was ex-
pressed in the VZ/SVZ of the neocortex (Figure S1C). For
further experiments, we generated two Grm7-specific short
hairpin RNA (shRNA) (Grm7shRNA-1 and Grm7shRNA-2)
plasmids and a Grm7 overexpression plasmid to efficiently
silence or overexpress GRM7 expression, respectively, in
embryonic NPCs (Figures 1E and 1F).
Grm7 knockdown decreased the immunostaining for
GRM7 in E16.5 brain sections following the electropora-
tion of the Grm7shRNA-1 or Grm7shRNA-2 plasmid into796 Stem Cell Reports j Vol. 4 j 795–810 j May 12, 2015 j ª2015 The Authothe embryonic brains at E13.5 (Figures 1G and 1H). A
similar result was obtained in cultured NPCs transfected
with these knockdown plasmids in vitro (Figure S1D).
Overall, the specific temporal and spatial expression
pattern of GRM7 suggests that GRM7 may be involved in
the regulation of the proliferation and differentiation of
NPCs during early cortical development.
GRM7Regulates Neural Progenitor Proliferation in the
Brain
To study the functional role of GRM7 in neurogenesis, we
investigated NPCs proliferation in vivo based on its expres-
sion in neural progenitor cells via IUE. The control orGrm7
shRNA plasmid was electroporated into E13.5 mouse
brains, which were collected 72 hr later for phenotypic
analysis. Analysis of the distribution of GFP-positive cells
revealed that Grm7 knockdown caused an augmentation
of GFP-positive cells in the VZ/SVZ and a corresponding
reduction in GFP-positive cells in the cortical plate (CP).
In the intermediate zone (IZ), the GFP-positive cell number
did not change (Figures 2A and 2B).
To further explore the effects of GRM7 on NPC prolifera-
tion, we injected pregnant dams with bromodeoxyuridine
(BrdU) 2 hr prior to collecting the electroporated brains.
The knockdown of Grm7 led to an increase in GFP and
BrdU double-positive neural progenitor cells (Figures 2C
and 2D) and in the mitotic index in the VZ/SVZ (Figures
S2A and S2B). We employed an in vitro culture system to
assess the function of GRM7 in neuronal proliferation.
Neural progenitor cells were isolated from E12.5 mouse
brains and cultured for 1 day; then, the cells were infected
with either control or Grm7 shRNA lentivirus. The infected
cells were cultured for 3 days under proliferative condi-
tions. Then, 5-ethynyl-20-deoxyuridine (EdU) was added
to the culture medium for 2 hr. The quantification of GFP
and EdUdouble-positive cells revealed that the knockdown
ofGrm7 in vitro increased neuronal proliferation compared
with the control treatment (Figure S2C).
To investigate the specific cell groups of proliferative pro-
genitor cells in the VZ/SVZ, we selected two types of neural
progenitor cell markers: PAX6 and TBR2. During the pro-
cess of early brain development, PAX6-positive RG cells
divide asymmetrically to self-renew and generate TBR2-
positive IP cells or neurons. Subsequently, IP cells divide
symmetrically to produce two neurons (Go¨tz and Huttner,
2005). Our results showed that Grm7 knockdown signifi-
cantly increased the proportion of PAX6-positive RG cells
(Figures 2E and 2F) at the expense of TBR2-positive IP
cells (Figures 2G and 2H). We also determined that Grm7
knockdown had no effect on the apoptosis of neural
progenitor cells (Figure S3A). Further analysis showed
that the proportion of GFP-BrdU-PAX6-positive cells was
increased (Figures S3B and S3C) but that the proportionrs
Figure 1. GRM7 Is Expressed in Embryonic Neural Progenitor Cells
(A) Western blot analysis of cortical lysates collected at various time points (E12.5, E15.5, or E18.5).
(B) GRM7 expression in the mouse cortex. Cortical sections of were collected from mice at E12.5 (left), E15.5 (middle), or E18.5 (right) and
were stained for GRM7. The scale bar represents 50 mm.
(C) E15.5 embryonic brain sections were co-stained with anti-GRM7 and anti-NESTIN antibodies (VZ/SVZ). The scale bar represents 25 mm.
(D) E15.5 embryonic brain sections were co-stained with anti-GRM7 and anti-PAX6 antibodies. The scale bar represents 25 mm.
(E and F) Western blot analysis shows the overexpression (empty PCDH expression vector as a control) or the knockdown of Grm7 (empty
pSicoR shRNA vector as control).
(G and H) Grm7 knockdown decreased the proportion of GRM7-GFP double-positive cells in utero. The control or Grm7 shRNA plasmid was
electroporated into E13.5 embryonic mouse brains, and the mice were sacrificed at E16.5. The percentage of GRM7-GFP double-positive
cells is shown (n = 3 independent experiments; error bars represent mean ± SEM; **p < 0.01). The scale bar represents 50 mm.
See also Figure S1.
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of GFP-BrdU-TBR2-positive cells was decreased (Figures
S3D and S3E) in the embryonic brain after electroporation
with a Grm7-knockdown plasmid compared to the control
plasmid. These data indicate that GRM7 loss of function
may cause an augmentation of proliferative cells located
in the VZ/SVZ.
Grm7 Knockdown Inhibits Cell-Cycle Exit by Neural
Progenitor Cells and Neuronal Differentiation
Our observations that Grm7 knockdown increased neural
progenitor proliferation and the number of GFP-positive
cells in the VZ/SVZ suggest that the differentiation of
NPCs into neurons may be affected by Grm7 knockdown.
To test this possibility, we performed cell-cycle exit analysis
following IUE at E13.5. BrdU was injected into pregnant
damsatE15.5,2daysafter IUE, andtheelectroporatedbrains
werecollectedatE16.5andsubjected to immunohistochem-
istry for BrdU and Ki67. Based on this analysis, we deter-
mined that Grm7 knockdown caused a significant decrease
in the proportion of GFP+BrdU+Ki67 cells relative to that
ofGFP+BrdU+ cells in theVZ/SVZ (Figures 3A and3B),which
implied thatGrm7 knockdown resulted in a decreased num-
ber of neural progenitor cells that exit the cell cycle.
To investigate whether this intervention directly leads
to reduced neuronal differentiation, we stained electropo-
rated brain sections with an anti-neuronal bIII-tubulin
(TUJ1) antibody. The quantification of GFP and TUJ1 dou-
ble-positive cells revealed that Grm7 knockdown led to a
significant decrease in the percentage of GFP and TUJ1 dou-
ble-positive cells, demonstrating that the loss of GRM7
expression resulted in a decrease in neuronal differentia-
tion (Figures 3C and 3D).
We also employed an in vitro culture system to assess the
function of GRM7 in neurogenesis. Neural progenitor cells
were isolated from E12.5 mouse brains and cultured forFigure 2. GRM7 Regulates Neural Progenitor Cell Proliferation
(A and B) Grm7 knockdown causes GFP-positive cell positioning defe
electroporated into E13.5 embryonic mouse brains, and the mice wer
region is shown (n = 3 independent experiments; error bars represent m
CP, cortical plate; IZ, intermediate zone; VZ/SVZ, ventricular zone/su
(C and D) BrdU incorporation is increased in Grm7 shRNA plasmid-elec
injected with BrdU (100mg/kg, i.p.) for 2 hr prior to sacrificing at E16.
bar graph shows the percentage of BrdU and GFP double-positive ce
dependent experiments; *p < 0.05, **p < 0.01; error bars represent m
(E and F) PAX6 and GFP double-positive cells are increased in Grm
collected 3 days after electroporation with either the control or Grm7
the percentage of PAX6 and GFP double-positive cells relative to the to
*p < 0.05, **p < 0.01; error bars represent mean ± SEM). The scale b
(G and H) TBR2 and GFP double-positive cells are decreased in the Grm7
electroporation with either the control or Grm7 shRNA plasmid at E13.5
and GFP double-positive cells relative to the total GFP-positive cells in
error bars represent mean ± SEM). The scale bar represents 20 mm.
Stem1 day; the cells were then infected with either control or
Grm7 shRNA lentivirus. The infected cells were cultured for
3 days under differentiating conditions, andneuronal differ-
entiation was subsequently assessed by co-staining with
anti-GFP and anti-TUJ1 antibodies. The quantification of
GFP and TUJ1 double-positive cells revealed that the knock-
down of Grm7 in vitro decreased neuronal differentiation
compared with the control treatment (Figures 3E and 3F).
Grm7 Knockdown Prohibits the Terminal Mitosis of
NPCs
To determine whether GRM7 regulates premature NPCs
terminal mitosis to control the differentiation process dur-
ing early cortical development, we conducted a BrdU birth-
dating study (Duque and Rakic, 2011). As shown in the
timeline, a single BrdU injection was administered to preg-
nant dams 1 day after electroporation, and the electropo-
rated brains were collected 5 days after electroporation
(Figure 4A). Because BrdU only labels cells that are in the
process of proliferation and in the S phase of mitosis (Now-
akowski et al., 1989), cells in their final mitotic division at
the time of BrdU administration become permanently
labeled with BrdU and progress toward neuronal differenti-
ation and migration to the cortical plate. However, BrdU
becomes diluted with each mitotic cycle in continually
proliferating NPCs; thus, BrdU cannot be detected using
an anti-BrdU antibody in continually proliferating NPCs
on E18.5 (Hasan et al., 2013). The quantification of the per-
centage of double-labeled (BrdU+GFP+) cells in all cortical
layers revealed a significant decrease in newly born neu-
rons in Grm7 shRNA plasmid-electroporated brains com-
pared with the control shRNA plasmid-electroporated
brains from littermates (Figures 4B–4E). These results indi-
cate thatGrm7 knockdown inhibits premature NPCs termi-
nal mitosis, thereby decreasing neural differentiation.cts in utero. The empty shRNA control or Grm7 shRNA plasmid was
e sacrificed at E16.5. The percentage of GFP-positive cells in each
ean ± SEM; *p < 0.05, **p < 0.01). The scale bar represents 50 mm.
bventricular zone.
troporated brains. The brains of mice electroporated at E13.5 were
5. The white arrows indicate GFP and BrdU double-positive cells. The
lls relative to the total GFP-positive cells in the VZ/SVZ (n = 3 in-
ean ± SEM). The scale bar represents 20 mm.
7 shRNA plasmid-electroporated brains. Cerebral cortical sections
shRNA plasmid at E13.5 were stained for PAX6. The bar graph shows
tal GFP-positive cells in the VZ/SVZ (n = 3 independent experiments;
ar represents 20 mm.
shRNA plasmid-electroporated brains. Brain sections at 3 days after
were stained for TBR2. The bar graph shows the percentage of TBR2
the VZ/SVZ (n = 3 independent experiments; *p < 0.05, **p < 0.01;
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Figure 3. Grm7 Knockdown Inhibits Neural Progenitor Differentiation
(A and B) Grm7 knockdown in progenitor cells reduces premature cell cycle exit in utero. The empty shRNA control or Grm7-shRNA plasmid
was electroporated into E13.5 embryonic brains, and BrdU was injected at E15.5. The mice were sacrificed at E16.5. The cell-cycle exit
index was calculated as the percentage of GFP-positive cells that exited the cell cycle (GFP+BrdU+Ki67) divided by the total GFP and
BrdU double-positive (GFP+BrdU+) cells. The white arrows indicate GFP+BrdU+Ki67 cells. The bar graph shows the percentage of
(legend continued on next page)
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Figure 4. GRM7 Is Required for Neural Progenitor Terminal Mitosis
(A) Timeline of the BrdU birth-dating experiment. The control or Grm7 shRNA plasmid was electroporated into E13.5 embryonic mouse
brains. BrdU was injected 24 hr after electroporation, and the brains were collected 5 days after electroporation.
(B and D) Low- (B) and high-magnification (D) confocal images of brain sections from control or Grm7 shRNA plasmid-electroporated mice
immunostained with an anti-BrdU antibody. The white arrows indicate GFP and BrdU double-positive cells. The scale bar represents 50 mm
(B) or 25 mm (D).
(C and E) The bar graph shows the percentage of BrdU and GFP double-positive cells relative to total GFP-positive cells in all cortical layers
or in the CP (n = 3 independent experiments; *p < 0.05, **p < 0.01; error bars represent mean ± SEM).Grm7 Knockdown Leads to Persistent Abnormal
Neuronal Development
To further determine the role of GRM7, we performed long-
term tracing of GFP cells during cortical development. The
control or Grm7 shRNA plasmid was electroporated intoGFP+BrdU+Ki67 cells relative to the total BrdU and GFP double-posit
**p < 0.01; error bars represent mean ± SEM). The scale bar represen
(C and D) Grm7 knockdown decreases neuronal differentiation in vivo.
of the control or Grm7-shRNA plasmid into the brain on E13.5. The qua
relative to the total GFP-positive cells is shown as a bar graph (n = 3 in
mean ± SEM). The scale bar represents 50 mm.
(E and F) Grm7 knockdown decreases neuronal differentiation in vitro
cultured for one day; the neural progenitor cells were subsequentl
quantification of the percentage of GFP and TUJ1 double-positive cel
independent experiments; *p < 0.05, **p < 0.01; error bars represen
See also Figures S2 and S3.
StemE13.5 mouse brains, and the brains were collected 5 days
later at E18.5. Compared with the control group, the
GFP-positive cell distribution was altered in the Grm7-
knockdown group. The number of GFP-positive cells was
reduced in the CP and the IZ but increased in the VZ/SVZive cells in the VZ/SVZ (n = 3 independent experiments; *p < 0.05,
ts 20 mm.
E16.5 brain sections were stained for TUJ1 after the electroporation
ntification of the percentage of GFP and TUJ1 double-positive cells
dependent experiments; *p < 0.05, **p < 0.01; error bars represent
. Neural progenitor cells were isolated from E12.5 mouse brains and
y infected with either the control or Grm7 shRNA lentivirus. The
ls relative to total GFP-positive cells is shown as a bar graph (n = 3
t mean ± SEM). The scale bar represents 25 mm.
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Figure 5. Grm7 Knockdown Affects Neuronal Development
(A and B) Grm7 knockdown causes GFP-positive cell positioning defects in vivo. The control or Grm7-shRNA plasmid was electroporated
into E13.5 embryonic mouse brains, and the mice were sacrificed at E18.5. The percentage of GFP-positive cells in each region is shown
(n = 3 independent experiments; *p < 0.05, **p < 0.01; error bars represent mean ± SEM). The scale bar represents 20 mm.
(legend continued on next page)
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(Figures 5A and 5B). The precocious or suppressed neuronal
differentiation upon Grm7 knockdown ultimately resulted
in a reduced number of TUJ1-positive upper-layer cortical
neurons at E18.5 (Figures 5C and 5D). Based on further
observation of high-resolution images, we determined
that Grm7 knockdown substantially induced abnormal
neuronal branching in vivo, as reported by a previous study
(Zhang et al., 2013). The leading processes in the control
groupwere long and straight, but those in theGrm7 knock-
down group were short and twisted, aberrantly branched,
or poorly developed (Figures 5E and 5F), as described in a
previous study (Zhang et al., 2013).
In vitro, GFP-positive cells were isolated from brains
24 hr post-electroporation, cultured for 72 hr, and then
stainedwith an anti-neuronal bIII-tubulin (TUJ1) antibody.
We observed a significant difference in neuronal mor-
phology between the control and Grm7-silenced cells in
culture. Grm7 knockdown resulted in reduced neurite
length compared with the control treatment (Figures 5G
and 5H). Interestingly, we also determined that the GFP-
positive Grm7-silenced cells more frequently failed to
develop into polarized neurons versus the control cells.
In addition, some GFP-positive Grm7-silenced cells were
round and exhibited very recently completed mitosis (Fig-
ure S4A). These results suggest that GRM7 is required for
neuronal development.
GRM7 Regulates Neurogenesis via the Modulation
CREB and YAP
It has been reported that both CREB (Stachowiak et al.,
2003) and YAP (Gee et al., 2011) are expressed in NPCs. Pre-
vious studies have shown that GRM7 controls the produc-
tion of cyclic AMP (cAMP) in the cytoplasm and that CREB
plays a critical role in neuronal proliferation via a cAMP-
dependent mechanism. We investigated whether there is
a relationship between GRM7 and CREB. In vitro, we deter-
mined that Grm7 knockdown increased the phosphoryla-
tion of CREB at Ser133. Conversely, Grm7 overexpression
decreased the phosphorylation of CREB at Ser133. YAP
acts as an important regulator of brain size and develop-
ment. Next, we examined whether GRM7 affects YAP
signaling. Our results showed that Grm7 knockdown(C and D) Decreased neuronal differentiation of Grm7-silenced cells i
TUJ1 after the electroporation of the control or Grm7-shRNA plasmid i
and TUJ1 double-positive cells relative to the total GFP-positive cell
experiments; *p < 0.05, **p < 0.01; error bars represent mean ± SEM
(E and F) High-magnification confocal images of the brain sections
branched processes compared to the control treatment (n = 3 independ
SEM). The scale bar represents 20 mm.
(G and H) GRM7 regulates the morphological maturation of neuron
electroporation brains for 72 hr were immunostained for TUJ1. The q
cells; *p < 0.05, **p < 0.01; error bars represent mean ± SEM). The s
Stemincreased the expression of YAP. Conversely, Grm7 overex-
pression decreased the expression of YAP, and subsequent
Grm7 knockdown rescued the phosphorylation of CREB
at Ser133 and the expression of the YAP (Figures 6A
and 6B).
Because GRM7 is a membrane protein that regulates the
flow of calcium ions, we used calmodulin (CaM) to bridge
the connection between GRM7 and CREB. We determined
that CaM overexpression led to an increase in the phos-
phorylation of CREB at Ser133 and in the expression of
YAP; these effects were similar to those ofGrm7 knockdown
(Figures 6C and 6D). We further investigated the effects of
CREB on YAP. When Creb was overexpressed, the expres-
sion of YAP was increased (Figure 6E). When Creb was
silenced, the expression of YAP was decreased (Figure 6F).
This result indicates cross-talk between CREB and YAP
signaling. To study whether CREB and YAP act in parallel,
we electroporated different plasmid combinations into
E13.5 mouse brains, and the brains were collected 72 hr
later for phenotypic analysis. The results showed that
Creb overexpression caused a phenotype similar to that of
Grm7 knockdown, and this phenotype was ameliorated
by simultaneous Yap knockdown. In addition, overexpres-
sion of YAP-S127A, a constitutively expressed form of YAP,
caused abnormalities similar to those caused by Grm7
knockdown; however, simultaneous Creb knockdown
failed to ameliorate these abnormalities (Figures 6G and
6H). Therefore, the results indicated that CREB and YAP
act downstream of GRM7 and that YAP acts downstream
of CREB.
A previous study has reported that the YAP protein accu-
mulates in the nucleus to promote cell proliferation (Fer-
nandez-L et al., 2009). Our results showed that the YAP
protein was accumulated in the nucleus uponGrm7 knock-
down (Figures 6I, 6J, S5C, and S5D).
Chromatin immunoprecipitation (ChIP) analysis was
then employed, and the results demonstrated that when
Creb was overexpressed, the amount of CREB that bound
to the 0.5-kb region (R1) of the Yap promoter was
increased (Figures 6K and S5A); the positive region R1
was selected based on a previous study (Wang et al.,
2013). The region of R2was randomly selected as a negativen vivo. Confocal images of E18.5 brain sections immunostained for
nto the brain on E13.5. The quantification of the percentage of GFP
s in all cortical layers is shown as a bar graph (n = 3 independent
). The scale bar represents 20 mm.
show that Grm7-knockdown results in the formation of abnormally
ent experiments; *p < 0.05, **p < 0.01; error bars represent mean ±
s in vitro. Images of GFP-positive cells cultured from 1 day post-
uantification of the neurite length is shown as a bar graph (n = 50
cale bar represents 25 mm.
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unrelated region. The structure of GRM7 has previously
been reported (Figure S4B) (Suh et al., 2008). Co-immuno-
precipitation was performed to confirm the interaction be-
tween GRM7 and CaM. Grm7 or a control expression
plasmid was cotransfected with Flag-CaM, and the results
indicated that CaM was immunoprecipitated by GRM7. It
has been reported that the C-terminal of G protein-coupled
receptors is important for signal transduction; therefore,
we deleted the C-terminal region of GRM7 to construct
the Grm7-CD plasmid (Figure S4C). When the C-terminal
region of GRM7 was deleted (GRM7-CD), CaM was not
immunoprecipitated by GRM7-CD under the identical
conditions (Figure 6L).
In our study, we observed that when Grm7 was
silenced, the percentage of cells exiting the cell cycle
(GFP+BrdU+Ki67) was decreased. Therefore, real-time
PCR was performed to analyze the expression of CyclinD1,
a cell cycle-related gene. The results showed that whenFigure 6. GRM7 Regulates CREB and YAP Signaling
(A and B) GRM7 regulates the phosphorylation of CREB and the express
(A) or the Grm7 overexpression plasmid (B) or the respective control
with a phospho-CREB (Ser133) (pCREB)-specific antibody. The expres
antibody (n = 3 independent experiments; b-ACTIN was used as a loadi
(C) CaM regulates the phosphorylation CREB and the expression of YAP
plasmid. CREB phosphorylation and YAP expression were determined vi
a loading control; *p < 0.05, **p < 0.01; error bars represent mean ±
(D) GRM7 and CaM regulate CREB phosphorylation. N2a cells were t
transfected with the Grm7 and CaM overexpression plasmids. CREB ph
experiments; b-ACTIN was used as a loading control; *p < 0.05, **p
(E and F) CREB regulates the expression of YAP. N2a cells were trans
pCREB, and YAP levels were determined via western blot (n = 3 indepen
**p < 0.01; error bars represent mean ± SEM).
(G and H) YAP acts downstream of CREB. The control, Grm7 shRNA, Creb
YAP-S127A and Creb shRNA plasmids were electroporated into E13.5
The percentage of GFP-positive cells in each region is shown (n = 3 in
mean ± SEM). The scale bar represents 50 mm.
(I and J) Grm7 knockdown causes YAP accumulation in the nucleus. N2
transfected cells were fixed two days later, and the cells were immuno
*p < 0.05, **p < 0.01; error bars represent mean ± SEM). The scale b
(K) CREB regulates the expression of YAP by binding to the Yap promote
plasmid. The binding of CREB to the Yap promoter was determined via
**p < 0.01; error bars represent mean ± SEM).
(L) CaM was immunoprecipitated by GRM7, but not by GRM7-CD. Protei
other for the GRM7 IP. The immunoprecipitated proteins were probed
(M) Grm7 knockdown increases the expression of CyclinD1. N2a cel
relative CyclinD1 mRNA level was detected via real-time PCR (n = 3 in
mean ± SEM).
(N) Yap overexpression increases the expression of CyclinD1. N2a cells w
relative CyclinD1 mRNA level was detected via real-time PCR (n = 3 in
mean ± SEM).
(O) YAP regulates the expression of CyclinD1 by binding to the Cycli
overexpression plasmid. The binding of YAP to the CyclinD1 promote
experiments; *p < 0.05, **p < 0.01; error bars represent mean ± SEM
See also Figures S4 and S5.
StemGrm7 was silenced, the expression of CyclinD1 was
increased, and a similar result was observed when Yap was
overexpressed (Figures 6M and 6N). ChIP was used to
detect whether YAP binds to the promoter region of Cy-
clinD1. The results showed that when Yap was overex-
pressed, the amount of YAP that bound to 0.2-kb region
(R10) of the CyclinD1 promoter was increased (Figures 6O
and S5B); the positive region R10 was selected based on a
previous study (Mizuno et al., 2012). The region of R20
was randomly selected as a negative unrelated region.
Further analysis showed that the immunostaining for
pCREB, YAP, and CYCLIND1 was enhanced when Grm7
was silenced (Figures S4D–S4I).
To support the roles of CREB, YAP, and CYCLIND1 in the
regulation of neurogenesis, we performed immunostaining
for CREB, phospho-CREB, YAP, and CYCLIND1 in the
developing neocortex at E12.5, E15.5, and E18.5. Our re-
sults showed that CREB was expressed in the entire cortexion of YAP. N2a cells were transfected with the Grm7-shRNA plasmid
. The phosphorylation of CREB was determined by immunoblotting
sion of YAP was determined by immunoblotting with a YAP-specific
ng control; *p < 0.05, **p < 0.01; error bars represent mean ± SEM).
. N2a cells were transfected with the control or CaM overexpression
a western blot (n = 3 independent experiments; b-ACTIN was used as
SEM).
ransfected with the control or CaM overexpression plasmid or co-
osphorylation was determined via western blot (n = 3 independent
< 0.01; error bars represent mean ± SEM).
fected with the control or CREB overexpression plasmid. The CREB,
dent experiments; b-ACTIN was used as a loading control; *p < 0.05,
overexpression, Creb overexpression and Yap shRNA, YAP-S127A, or
embryonic mouse brains, and the mice were sacrificed at E16.5.
dependent experiments; *p < 0.05, **p < 0.01; error bars represent
a cells were transfected with the control shRNA or Grm7shRNA-2. The
stained with an anti-YAP antibody (n = 4 independent experiments;
ar represents 5 mm.
r. N2a cells were transfected with the control or Creb overexpression
ChIP and real-time PCR (n = 3 independent experiments; *p < 0.05,
n lysates were divided into two parts, one for the control IP and the
with anti-Flag antibodies to detect Flag-CaM.
ls were transfected with the control or Grm7 shRNA plasmid. The
dependent experiments; *p < 0.05, **p < 0.01; error bars represent
ere transfected with the control or Yap overexpression plasmid. The
dependent experiments; *p < 0.05, **p < 0.01; error bars represent
nD1 promoter. N2a cells were transfected with the control or Yap
r was determined via ChIP and real-time PCR (n = 3 independent
).
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Figure 7. The Neurogenesis Defects Caused by Grm7 Knockdown Could Be Ameliorated
(A–D) The expression patterns of CREB, pCREB, YAP, and CYCLIND1 support their roles in the regulation of neurogenesis. Cortical sections
of E12.5, E15.5, and E18.5 mice were collected and immunostained for CREB, pCREB, YAP, and CYCLIND1. The scale bar represents 60 mm.
(legend continued on next page)
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at different developmental stages. Phospho-CREB was ex-
pressed in the VZ/SVZ at E12.5 and accumulated in the IZ
and theCP at E15.5 and E18.5, and a subset pCREB-positive
cells remained in the VZ/SVZ at E15.5 and E18.5. This
expression pattern is consistent with a previous report
that pCREB is involved in the process of proliferation and
consistently participates in the process of differentiation
(Mantamadiotis et al., 2012). YAP and CYCLIND1 were ex-
pressed in the VZ/SVZ of the brain, consistent with their
role in promoting proliferation (Figures 7A–7D).
Our results of phenotypic analysis following IUE showed
that Grm7 overexpression, Creb knockdown, or Yap knock-
down ameliorated the defects in neurogenesis caused by
Grm7 knockdown (Figures 7G and 7H). These results indi-
cate that CREB and YAP may act as downstream regulatory
effectors of GRM7 signaling during early cortical develop-
ment. To study whether Creb or Yap knockdown amelio-
rates these morphological changes, we performed IUE at
E13.5 and phenotypic analysis at E18.5. The 3D reconstruc-
tion results also showed that Creb or Yap knockdown ame-
liorates these morphological changes (Figures 7I and 7J).DISCUSSION
GRM7 may be associated with brain developmental disor-
ders, including ADHD (Elia et al., 2012) and ASD (Yang
and Pan, 2013). However, there is no direct evidence
regarding whether or how GRM7 regulates brain develop-
ment and neurogenesis. Neurogenesis in the developing
brain is dynamically regulated by multiple factors and
pathways. Here, we provide several lines of evidence
demonstrating that GRM7 is essential for brain cortical
neurogenesis. These data indicate a role of GRM7 in the
developing mammalian cortex. Our results may provide
an understanding of the genetic mechanism underlying
brain pathophysiology and may reveal potential targets
for therapeutic intervention.
Metabotropic glutamate receptors, which contain seven
transmembrane domains, belong to the G protein-coupled
receptor family, which is actively involved in brain devel-(E and F) BrdU incorporation is increased in Creb-, Yap-, or CyclinD1-ove
and BrdU was injected 2 hr prior to sacrificing the mice at E16.5. The
shows the percentage of BrdU and GFP double-positive cells relative
experiments; *p < 0.05, **p < 0.01; error bars represent mean ± SEM
(G and H) Grm7 overexpression, Creb knockdown, or Yap knockdown am
in utero. The indicated plasmids were electroporated into E13.5 e
The percentage of GFP-positive cells in each region is shown (n = 3 in
mean ± SEM). The scale bar represents 50 mm.
(I and J) Grm7 overexpression, Creb knockdown, or Yap knockdown ame
indicated plasmids were electroporated into E13.5 embryonic mouse
experiments; *p < 0.05, **p < 0.01; error bars represent mean ± SEM
Stemopment and function (Conn and Pin, 1997). GRM7 is a
type III GRM family member, and increasing evidence
indicates that the mutation of GRM7 is closely correlated
with brain diseases (Elia et al., 2012; Yang and Pan, 2013).
The activation of GRM7 by glutamate depends on its mem-
brane localization. Previous studies have shown that both
PICK1 binding and PKC phosphorylation are required for
the stable surface expression of GRM7 (Dev et al., 2000;
Suh et al., 2008). Our results show that GRM7 is required
for embryonic cortical development. Using IUE, we deter-
mined that Grm7 knockdown leads to neurogenesis
defects, including increased proliferation and decreased
differentiation of NPCs. Grm7 knockdown results in
decreased premature NPC terminal mitosis. We provide ev-
idence that GRM7 is essential for neuronal morphofunc-
tional changes and maturation.
Previous studies have shown that CREB (Mantamadiotis
et al., 2012) and YAP (Vassilev et al., 2001) are critical mod-
ulators of the process of brain development. It is known
that some G protein-coupled receptors activate the
cAMP/CREB pathway (Neves et al., 2002). Because CREB
and YAP regulate NSC proliferation, we hypothesized that
GRM7 regulates neurogenesis via these signaling effectors.
Our results demonstrated that GRM7 regulates neural
progenitor proliferation and differentiation via the modu-
lation of CREB phosphorylation at Ser133 and YAP expres-
sion. When GRM7 function was lost, the phosphorylation
of CREB at Ser133 (active form) and the expression of YAP
(active form) were increased. In our study, we also observed
that when Grm7 was silenced, the number of cells exiting
the cell cycle (GFP+BrdU+Ki67) was decreased. We also
found that when Grm7 was silenced, the expression of Cy-
clinD1 was increased; a similar result was observed when
Yapwas overexpressed. The increase in the active YAP level
caused by Grm7 knockdown subsequently induced the
expression of CyclinD1, which promoted NPCs prolifera-
tion; these events are consistent with the known function
of YAP.
During early cortical development, the expression of
GRM7 peaks at E15. The high expression of GRM7 at E15
suggests that it plays a critical role during this importantrexpressing brains. The brains of mice were electroporated at E13.5,
arrows indicate GFP and BrdU double-positive cells. The bar graph
to the total GFP-positive cells in the VZ/SVZ (n = 3 independent
). The scale bar represents 20 mm.
eliorates the early neurogenesis defect caused by Grm7 knockdown
mbryonic mouse brains, and the mice were sacrificed at E18.5.
dependent experiments; *p < 0.05, **p < 0.01; error bars represent
liorates the morphological changes caused by Grm7 knockdown. The
brains, and the mice were sacrificed at E18.5 (n = 3 independent
).
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period of neurogenesis, and this hypothesis is consistent
with our findings. Our results also demonstrated that
Grm7 knockdown leads to cell morphological changes.
Therefore, GRM7 may mediate neuronal morphofunc-
tional changes and maturation, thus enabling mature neu-
rons to integrate intracortical inputs.
In our study, using IUE, we demonstrated that Grm7
knockdown leads to abnormal neuronal branching and dis-
tribution. Based on thesemorphological changes caused by
Grm7 knockdown, GRM7 may also participate in neuronal
migration. The morphological change from a multipolar
to a bipolar morphology is a crucial event that is coupled
to the migration of the immature neuron from the
VZ to the CP in an inside-out pattern. During brain devel-
opment, the CREB protein has been associated with
neuronal migration, and the phosphorylation of CREB at
Ser133 is increased during the late phase of migration (Gia-
chino et al., 2005). GRM7may regulate neuronalmigration
by modulating CREB phosphorylation at Ser133. YAP
regulates the proliferation and differentiation of NPCs;
however, whether YAP is involved in neuronal migration
has not been reported previously and requires further
investigation.
In summary, we demonstrate that GRM7 functions as a
modulator of neurogenesis. We identify CREB, YAP, and
CYCLIND1 as the downstream targets of GRM7. The phos-
phorylation of CREB at Ser133 and the expression of YAP
and CyclinD1 are modulated by GRM7, thereby regulating
neurogenesis. Future behavioral studies will facilitate a
deeper understanding of the relationship between GRM7
and developmental brain disorders.EXPERIMENTAL PROCEDURES
In Utero Electroporation
The detailed protocols have been previously described (Lv et al.,
2014). Briefly, pregnant (E13.5) ICR (Institute of Cancer Research)
mice were anesthetized with pentobarbital sodium and and the
uterine horns were exposed. Then, 1 ml recombinant plasmid (final
concentration 2 mg/ml) mixed with enhanced GFP plasmid (Venus-
GFP) at a 3:1 mol ratio and fast green (2 mg/ml; Sigma) was microin-
jected into the mouse fetal brain ventricles with glass capillaries.
Five electric pulses of 40 V for 50 ms were applied at intervals of
950 ms across the head using an electroporator and platinum elec-
trodes (Manual BTX ECM830). Following electroporation, the
mice were sacrificed at E14.5, E16.5, or E18.5 and used for pheno-
type analysis. The brains were dissected and fixed in 4% parafor-
maldehyde (PFA) overnight at 4C and then dehydrated in 30%
sucrose.
BrdU Labeling
For NPC proliferation analysis, BrdU (100 mg/kg) was adminis-
tered to pregnant female mice 72 hr after electroporation via
an intraperitoneal (i.p.) injection. The embryonic brains were808 Stem Cell Reports j Vol. 4 j 795–810 j May 12, 2015 j ª2015 The Authocollected for phenotype analysis after BrdU labeling for 2 hr as pre-
viously described (Singh et al., 2010).
For the cell-cycle exit experiment, BrdU (100mg/kg)was adminis-
tered to mice 2 days after electroporation via i.p. injection. After
24 hr, the mouse brains were separated and processed. Then, the
brains were co-stained with anti-BrdU and anti-Ki67 antibodies for
analysis aspreviouslydescribed (Mao et al., 2009; Singhet al., 2010).
For the premature NPC terminal mitosis experiment, BrdU
(100 mg/kg) was administered to pregnant female mice 24 hr after
electroporation via an i.p. injection. The embryonic brains were
collected for phenotype analysis after BrdU labeling for 4 days as
previously described (Gambello et al., 2003; Hasan et al., 2013).Immunostaining
Coronal sections (15 mm) were harvested using a freezing micro-
tome (Leica CM1950), and the brain sections were placed on the
adhesion microscope slides for analysis according to a previous
study (Mao et al., 2009). Immunohistochemistry (IHC) was done
on 15-mm-thick coronal brain sections; the brain sections were
washed with 1% PBST (1% Triton X-100 in 1M PBS [pH 7.4]), fixed
30minby 4%PFA, andwashed by PBST for 15min three times. The
slices were incubatedwith blocking buffer (5%BSA in 1%PBST) for
1 hr at room temperature. When IHC was required for BrdU, the
brain sections were washed using PBST for 15 min three times.
Sequentially, the sections were subjected to HCl treatment, incu-
bated in ice-cold 1 N HCl for 10 min, in 2 N HCl for 10 min at
room temperature, and in 2 NHCl for 20 min at 37C. After finish-
ing the above steps, PBST was used to wash the sections three
times. Blocking was processed as previously described. The brain
slices were incubated in primary antibodies at 4C overnight.
The brain sections were then washed in PBST for 15 min three
times followed by secondary antibodies conjugated with Alexa
Fluor dyes (1:1,000 dilution; Jackson ImmunoResearch) in PBST
buffer for 1 hr at room temperature. The brain sections were
washed three times for 15 min in PBST, incubated with 2 mg/ml
DAPI for 2 min, and washed three times for 5 min with PBST.
Immunostaining for cultured cells was performed according to
the following procedure: the cells were washed with PBST (0.1%
TritonX-100 in 1MPBS), fixed in 4%PFA, blocked by 5%BSA (San-
gon, in 0.1% PBST), incubated with primary antibodies overnight
at 4C, and visualized using fluorescence-labeling secondary
antibodies.Western Blotting and Co-immunoprecipitation
Cell pellets were lysed with RIPA (Solarbio) in combination with
10mMPMSF and cocktail (Sigma) for 5min on ice and then centri-
fuged for 5 min at 4C to eliminate cell debris. Next, the protein
samples (in 43 loading buffer) were loaded onto SDS-PAGE gels.
Subsequently, the protein bands were transferred to nitrocellu-
lose or polyvinylidene fluoride membranes and blocked in 5%
nonfat milk in PBS-T (PBS with 0.1% Tween-20) for 1 hr at
room temperature. The membranes were then incubated at 4C
overnight with primary antibody and IRDye 800CW or 680CW
(LI-COR Biosciences) donkey anti-mouse or anti-rabbit secondary
antibodies were used to visualize the bands.
For co-immunoprecipitation, fresh extracted protein samples
were incubated with 30 ml Dynabeads Protein A (Life Technology)rs
overnight at 4C, which had been previously incubated with pri-
mary antibody (1 ml in PBS including 0.02% Tween-20). The
Dynabeads-antibody-sample complex was washed three times to
remove the supernatant using a magnet. 30 ml 13 loading buffer
was added to the complex and then placed in 70C water for
10min for complex depolymerization. Next, the 20-ml supernatant
was collected for western blotting.
RT-PCR
The total RNA was extracted by using the TRIzol (Invitrogen)
according to the manufacturer’s instructions. FastQuant RT Kit
(with DNase, TIANGEN) was used to get first-strand cDNA. The
primers used for real-time PCR were as follows: CyclinD1, 50-
GCCTACAGCCCTGTTACCTG-30 (forward) and 50-ATTTCATCCC
TACCGCTGTG-30 (reverse); b-Actin, 50-GGTGGGAATGGGTCA
GAAGG-30 (forward) and 50-AGGAAGAGGATGCGCCAGTG-30
(reverse).
Confocal Imaging and Statistical Analysis
All images were captured with a Zeiss 780 laser scanning confocal
microscope and analyzed with Photoshop CS4 (Adobe). Statistical
analyses were performed using a one-way ANOVA or t test (*p <
0.05, **p < 0.01). All bar graphs are shown as the means ± SEM,
and error bars represent mean ± SEM.
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